MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2022 International Congress

September 15-18, 2022. Madrid, Spain.

View by Title View Categories
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • Understanding the continuing educational needs of US clinicians managing OFF episodes in Parkinson’s disease

    W. Cerenzia, S. Wiley, B. Coleman, S. Stacy, E. Jen, K. Farahmand (Birmingham, USA)

  • Unilateral Hypertrophic Olivary Degeneration in Anti-GAD-associated Encephalomyelitis

    O. Turgunkhujaev, YU. Seliverstov, V. Fominykh, L. Brylev (Moscow, Russian Federation)

  • Unraveling the Potential of Specialized Allied Health Therapy in Parkinson’s Disease

    AH. Talebi, JHL. Ypinga, M. Munneke, B. Bloem, SKL. Darweesh (Nijmegen, Netherlands)

  • Unravelling Hidden Mutations Behind the Heterozygos SYNE1 Genotype

    Y. Salamatova, L. Terpak, E. Giatour, N. Shneyder (jacksonville, USA)

  • Updated Parkinson’s disease motor subtypes classification and correlation to CSF HVA and 5-HIAA levels

    M. Schiess, J. Suescun, A. Haque, K. Block, E. Tharp, T. Ellmore, C. Adams (Houston, USA)

  • Use of a wearable medical device for LCIG tube adjustment: a user case

    JHR. Herreros Rodríguez, AEL. Esquivel López, JP. Romero Muñoz, M. Llaguno Velasco (Madrid, Spain)

  • Use of alternative healing for Parkinson’s disease in Kenya

    N. Fothergill-Misbah, R. Walker (Southampton, United Kingdom)

  • Use of apomorphine infusion pump in the elderly population : a 5 years follw up study on efficacy, safety and tolerability in a cohort bases study

    C. Borrue- Fernandez, M. Mata, C. Jimeno, M. Almarcha (San Sebastian Reyes, Spain)

  • Use of bupivacaine in the evaluation of acute secondary cervical dystonia (CD)

    JR. Chai, S. Bansal, C. Li, M. Jog (London, Canada)

  • USE OF NIGHT TIME CONTINUOUS SUBCUTANEOUS INFUSION OF APOMORPHINE (NCSAI) IN ADVANCED PARKINSON’S DISEASE: A SERIES OF 37 CASES.

    AK. Vargas Mendoza, B. López López, M. Díaz Castela, J. Molina Gil, P. Zunzunegui Arroyo, A. Criado Antón, ME. Suárez Sanmartín, C. García Fernández (Oviedo, Spain)

  • « Previous Page
  • 1
  • …
  • 145
  • 146
  • 147
  • 148
  • 149
  • …
  • 153
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Patients with Essential Tremor Live Longer than their Relatives
  • #23624 (not found)
  • The hardest symptoms that bother patients with Parkinson's disease
  • Three cases of early tremor in the course of Guillain-Barré Syndrome
  • The impact of gastric acid suppressants and antacids on levodopa plasma concentration in patients with Parkinson’s disease
  • To be or not to bupropion: a drug-induced parkinsonism?
  • The Role of MRI and DaTscan in Vascular Parkinsonism: A Case Report
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley